B.K. PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
B.K. PHARMA
Largest movements
- Cash -€45,247
down €45,247 (-36.7%), from €123,290 to €78,043
mainly Debts after one year (-€35,090) and Investment in fixed assets (net) (-€22,891)
- Receivables within one year +€12,444
up €12,444 (+16.1%), from €77,517 to €89,961
of which Trade receivables: +€11,911
- Debts after one year -€35,090
down €35,090 (-63.9%), from €54,914 to €19,824
- Reserves +€25,000
up €25,000 (+22.3%), from €111,900 to €136,900
of which Distributable reserves: +€25,000
- Current portion of long-term debt -€20,790
down €20,790 (-30.5%), from €68,117 to €47,327
- Trade debts +€4,606
up €4,606 (+3.5%), from €132,808 to €137,414
- Gross operating margin -€38,529
down €38,529 (-25.5%), from €151,230 to €112,702
- Taxes -€11,746
down €11,746 (-51.3%), from €22,875 to €11,129
- Financial charges -€3,069
down €3,069 (-31.2%), from €9,853 to €6,784
- Financial income -€2,950
down €2,950 (-30.2%), from €9,759 to €6,809
- Depreciation +€2,949
up €2,949 (+14.7%), from €20,066 to €23,015
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €450,980 | €421,476 | -€29,504 | -6.5% |
| Fixed assets | 21/28 | €172,821 | €172,697 | -€124 | -0.1% |
| Tangible fixed assets | 22/27 | €170,575 | €170,451 | -€124 | -0.1% |
| Land and buildings | 22 | €123,287 | €111,032 | -€12,255 | -9.9% |
| Plant, machinery and equipment | 23 | €5,214 | €2,157 | -€3,057 | -58.6% |
| Furniture and vehicles | 24 | €56 | €20,950 | +€20,894 | +37071.6% |
| Other tangible fixed assets | 26 | €42,017 | €36,312 | -€5,705 | -13.6% |
| Financial fixed assets | 28 | €2,247 | €2,247 | = | 0.0% |
| Current assets | 29/58 | €278,158 | €248,778 | -€29,380 | -10.6% |
| Amounts receivable after more than one year | 29 | €60,000 | €60,000 | = | 0.0% |
| Other amounts receivable | 291 | €60,000 | €60,000 | = | 0.0% |
| Stocks and contracts in progress | 3 | €15,006 | €19,002 | +€3,996 | +26.6% |
| Stocks | 30/36 | €15,006 | €19,002 | +€3,996 | +26.6% |
| Amounts receivable within one year | 40/41 | €77,517 | €89,961 | +€12,444 | +16.1% |
| Trade receivables | 40 | €61,971 | €73,882 | +€11,911 | +19.2% |
| Other amounts receivable | 41 | €15,546 | €16,079 | +€533 | +3.4% |
| Cash at bank and in hand | 54/58 | €123,290 | €78,043 | -€45,247 | -36.7% |
| Deferred charges and accrued income | 490/1 | €2,346 | €1,772 | -€574 | -24.5% |
| Total equity and liabilities | 10/49 | €450,980 | €421,476 | -€29,504 | -6.5% |
| Equity | 10/15 | €165,977 | €192,565 | +€26,588 | +16.0% |
| Contributions | 10/11 | €6,500 | €6,500 | = | 0.0% |
| Capital | 10 | €6,500 | €6,500 | = | 0.0% |
| Issued capital | 100 | €19,000 | €19,000 | = | 0.0% |
| Uncalled capital | 101 | €12,500 | €12,500 | = | 0.0% |
| Reserves | 13 | €111,900 | €136,900 | +€25,000 | +22.3% |
| Non-distributable reserves | 130/1 | €1,900 | €1,900 | = | 0.0% |
| Legal reserve | 130 | €1,900 | €1,900 | = | 0.0% |
| Distributable reserves | 133 | €110,000 | €135,000 | +€25,000 | +22.7% |
| Profit (loss) carried forward | 14 | €47,577 | €49,165 | +€1,588 | +3.3% |
| Amounts payable | 17/49 | €285,003 | €228,911 | -€56,092 | -19.7% |
| Amounts payable after more than one year | 17 | €54,914 | €19,824 | -€35,090 | -63.9% |
| Financial debts | 170/4 | €54,914 | €19,824 | -€35,090 | -63.9% |
| Amounts payable within one year | 42/48 | €230,089 | €209,087 | -€21,001 | -9.1% |
| Current portion of amounts payable after more than one year | 42 | €68,117 | €47,327 | -€20,790 | -30.5% |
| Trade debts | 44 | €132,808 | €137,414 | +€4,606 | +3.5% |
| Suppliers | 440/4 | €132,808 | €137,414 | +€4,606 | +3.5% |
| Taxes, remuneration and social security | 45 | €25,964 | €22,346 | -€3,618 | -13.9% |
| Taxes | 450/3 | €16,700 | €15,416 | -€1,284 | -7.7% |
| Remuneration and social security | 454/9 | €9,264 | €6,930 | -€2,334 | -25.2% |
| Other amounts payable | 47/48 | €3,200 | €2,000 | -€1,200 | -37.5% |
| Remuneration, social security and pensions | 62 | €43,759 | €45,346 | +€1,587 | +3.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €20,066 | €23,015 | +€2,949 | +14.7% |
| Other operating charges | 640/8 | €6,138 | €6,649 | +€511 | +8.3% |
| Gross operating margin | 9900 | €151,230 | €112,702 | -€38,529 | -25.5% |
| Operating profit (loss) | 9901 | €81,267 | €37,692 | -€43,575 | -53.6% |
| Financial income | 75/76B | €9,759 | €6,809 | -€2,950 | -30.2% |
| Recurring financial income | 75 | €9,759 | €6,809 | -€2,950 | -30.2% |
| Financial charges | 65/66B | €9,853 | €6,784 | -€3,069 | -31.2% |
| Recurring financial charges | 65 | €9,853 | €6,784 | -€3,069 | -31.2% |
| Profit (loss) for the period before taxes | 9903 | €81,173 | €37,717 | -€43,455 | -53.5% |
| Income taxes | 67/77 | €22,875 | €11,129 | -€11,746 | -51.3% |
| Profit (loss) for the period | 9904 | €58,298 | €26,588 | -€31,710 | -54.4% |
| Profit (loss) for the period to be appropriated | 9905 | €58,298 | €26,588 | -€31,710 | -54.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.